Go Pro

Artivion (AORT) Financials

Artivion logo
$26.71 +0.33 (+1.27%)
As of 01:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Artivion

Annual Income Statements for Artivion

This table shows Artivion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
4.01 122 3.70 -2.84 1.72 -17 -15 -19 -31 -13 9.77
Consolidated Net Income / (Loss)
4.01 11 3.70 -2.84 1.72 -17 -15 -19 -31 -13 9.77
Net Income / (Loss) Continuing Operations
4.01 122 3.70 -2.84 1.72 -17 -15 -19 -31 -13 9.77
Total Pre-Tax Income
5.87 18 3.56 -6.39 1.64 -17 -15 -15 -22 -7.51 15
Total Operating Income
5.35 22 7.97 9.31 17 2.44 8.12 6.20 5.74 39 34
Total Gross Profit
91 238 129 173 183 168 198 203 229 249 284
Total Revenue
146 180 190 263 276 253 299 314 354 389 441
Operating Revenue
146 180 190 263 276 253 299 314 354 389 441
Total Cost of Revenue
55 -57 61 90 93 85 101 111 125 140 157
Operating Cost of Revenue
55 180 61 90 93 85 101 111 125 140 157
Total Operating Expenses
85 105 121 164 166 165 189 196 223 210 250
Selling, General & Admin Expense
75 92 101 141 143 141 170 157 209 181 226
Research & Development Expense
10 13 19 23 23 24 36 39 29 28 31
Other Special Charges / (Income)
- - - - - - -16 0.00 -14 0.00 -7.00
Total Other Income / (Expense), net
0.51 -3.41 -4.41 -16 -15 -20 -23 -21 -27 -46 -19
Interest Expense
-0.06 3.04 4.88 16 15 17 17 18 25 38 29
Interest & Investment Income
0.94 0.07 0.21 0.23 0.74 0.22 0.08 0.15 1.08 1.47 0.76
Other Income / (Expense), net
-0.48 -0.44 0.26 -0.14 -1.25 -3.13 -6.14 -3.11 -3.11 -9.91 9.52
Income Tax Expense
1.86 7.63 -0.14 -3.55 -0.08 -0.49 0.01 4.21 9.10 5.85 5.01
Basic Earnings per Share
$0.14 $0.33 $0.11 ($0.08) $0.05 ($0.44) ($0.38) ($0.48) ($0.75) ($0.32) $0.22
Weighted Average Basic Shares Outstanding
27.74M 31.86M 33.01M 36.41M 37.12M 37.86M 38.98M 40.03M 40.74M 41.68M 45.34M
Diluted Earnings per Share
$0.14 $0.32 $0.11 ($0.08) $0.05 ($0.44) ($0.38) ($0.48) ($0.75) ($0.32) $0.21
Weighted Average Diluted Shares Outstanding
28.54M 32.82M 34.16M 36.41M 37.86M 37.86M 38.98M 40.03M 40.74M 41.68M 47.16M
Weighted Average Basic & Diluted Shares Outstanding
28.60M 32.70M 33.70M 35.50M 39.08M 38.96M 40.12M 40.56M 41.23M 42.05M 47.88M

Quarterly Income Statements for Artivion

This table shows Artivion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-3.98 7.53 -2.12 -2.29 -16 -0.51 1.35 6.50 2.43 1.42 -14
Consolidated Net Income / (Loss)
-3.98 7.53 -2.12 -2.29 -16 -0.51 1.35 6.50 2.43 1.42 -14
Net Income / (Loss) Continuing Operations
-3.98 7.53 -2.12 -2.29 -16 -0.51 1.35 6.50 2.43 1.42 -14
Total Pre-Tax Income
-0.59 13 -2.43 -1.27 -17 -2.30 3.48 7.06 6.54 0.34 -12
Total Operating Income
3.17 25 6.51 4.39 2.67 2.15 8.38 13 11 5.79 -8.36
Total Gross Profit
61 63 63 61 62 64 73 74 73 75 81
Total Revenue
94 97 98 96 97 99 113 113 116 116 126
Operating Revenue
94 97 98 96 97 99 113 113 116 116 126
Total Cost of Revenue
33 34 35 35 36 35 40 39 43 41 45
Operating Cost of Revenue
33 34 35 35 36 35 40 39 43 41 45
Total Operating Expenses
58 38 57 57 59 61 65 62 62 70 89
Selling, General & Admin Expense
50 31 49 50 51 55 58 57 57 61 80
Research & Development Expense
7.65 6.95 7.50 6.61 7.40 6.73 7.06 8.08 9.12 8.84 9.06
Total Other Income / (Expense), net
-3.76 -13 -8.93 -5.65 -19 -4.44 -4.90 -5.48 -4.14 -5.45 -3.34
Interest Expense
6.24 11 8.30 8.41 9.74 7.66 7.27 6.12 8.19 5.37 7.25
Interest & Investment Income
0.40 0.37 0.35 0.37 0.37 0.14 0.07 0.24 0.31 0.21 0.37
Other Income / (Expense), net
2.08 -1.41 -0.98 2.39 -9.90 3.08 2.30 0.40 3.74 -0.29 3.55
Income Tax Expense
3.38 5.25 -0.31 1.02 -0.12 -1.79 2.14 0.55 4.11 -1.08 1.81
Basic Earnings per Share
($0.10) $0.18 ($0.05) ($0.05) ($0.40) ($0.01) $0.03 $0.14 $0.06 $0.03 ($0.28)
Weighted Average Basic Shares Outstanding
40.74M 41.29M 41.68M 41.84M 41.68M 42.23M 44.30M 47.23M 45.34M 48.07M 48.54M
Diluted Earnings per Share
($0.10) $0.18 ($0.05) ($0.05) ($0.40) ($0.01) $0.03 $0.13 $0.06 $0.03 ($0.28)
Weighted Average Diluted Shares Outstanding
40.74M 47.89M 41.68M 41.84M 41.68M 42.23M 45.38M 48.78M 47.16M 49.73M 48.54M
Weighted Average Basic & Diluted Shares Outstanding
41.23M 41.73M 41.89M 41.92M 42.05M 42.70M 47.18M 47.37M 47.88M 48.54M 48.76M

Annual Cash Flow Statements for Artivion

This table details how cash moves in and out of Artivion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
4.21 14 -17 1.48 -7.94 28 -6.95 -16 20 -5.48 11
Net Cash From Operating Activities
11 20 11 9.88 16 12 -2.59 -5.15 19 22 40
Net Cash From Continuing Operating Activities
11 20 11 9.88 16 12 -2.59 -5.15 19 22 40
Net Income / (Loss) Continuing Operations
4.01 11 3.70 -2.84 1.72 -17 -15 -19 -31 -13 9.77
Consolidated Net Income / (Loss)
4.01 11 3.70 -2.84 1.72 -17 -15 -19 -31 -13 9.77
Depreciation Expense
5.86 8.38 9.75 18 18 21 24 22 23 24 22
Non-Cash Adjustments To Reconcile Net Income
5.81 0.05 9.71 9.12 17 26 17 25 16 35 29
Changes in Operating Assets and Liabilities, net
-4.23 0.51 -12 -14 -22 -18 -29 -34 10 -24 -22
Net Cash From Investing Activities
-4.49 -79 -171 -6.72 -24 -73 5.66 -11 -0.50 -28 -42
Net Cash From Continuing Investing Activities
-4.49 -79 -171 -6.72 -24 -73 5.66 -11 -0.50 -28 -42
Purchase of Property, Plant & Equipment
-3.49 -6.20 -6.63 -5.79 -8.07 -7.33 -13 -11 -9.75 -11 -39
Sale of Property, Plant & Equipment
- - - - 0.00 0.00 19 0.00 14 0.00 5.00
Other Investing Activities, net
-0.61 -0.13 -0.09 -0.93 -0.87 -5.52 -0.25 0.00 -5.00 -17 -8.00
Net Cash From Financing Activities
-2.81 73 143 -2.56 -1.49 94 -12 -1.64 0.87 2.20 11
Net Cash From Continuing Financing Activities
-2.81 73 143 -2.56 -1.49 94 -12 -1.64 0.87 2.20 11
Repayment of Debt
- -3.70 -83 -4.32 -3.51 -40 -5.87 -3.21 -6.09 -216 -4.91
Issuance of Debt
0.46 76 225 0.00 0.00 130 - 0.00 0.00 213 0.00
Issuance of Common Equity
1.53 2.20 3.13 3.85 4.76 2.43 3.76 3.37 3.96 5.73 13
Other Financing Activities, net
-1.39 -0.70 -1.61 -2.10 -2.74 0.82 -10 -1.80 3.00 0.00 3.12
Effect of Exchange Rate Changes
0.07 - - - - -5.19 2.20 - 0.40 -1.73 2.32

Quarterly Cash Flow Statements for Artivion

This table details how cash moves in and out of Artivion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
5.46 -7.82 3.90 1.15 -2.71 -16 16 20 -8.52 -9.14 22
Net Cash From Operating Activities
11 -5.49 6.14 11 10 -17 15 22 20 1.15 -1.27
Net Cash From Continuing Operating Activities
11 -5.49 6.14 11 10 -17 15 22 20 1.15 -1.27
Net Income / (Loss) Continuing Operations
-3.98 7.53 -2.12 -2.29 -16 -0.51 1.35 6.50 2.43 1.42 -14
Consolidated Net Income / (Loss)
-3.98 7.53 -2.12 -2.29 -16 -0.51 1.35 6.50 2.43 1.42 -14
Depreciation Expense
5.82 5.91 5.89 6.11 6.30 5.45 5.54 5.72 5.76 6.34 6.75
Non-Cash Adjustments To Reconcile Net Income
4.98 9.79 7.55 7.58 16 11 11 5.35 2.42 11 11
Changes in Operating Assets and Liabilities, net
4.02 -29 -5.18 0.05 4.74 -32 -3.01 4.69 8.96 -17 -5.29
Net Cash From Investing Activities
-2.67 -3.61 -2.51 -11 -11 -3.64 -3.29 -4.61 -31 -11 -129
Net Cash From Continuing Investing Activities
-2.67 -3.61 -2.51 -11 -11 -3.64 -3.29 -4.61 -31 -11 -129
Purchase of Property, Plant & Equipment
-2.67 -3.61 -2.51 -3.64 -1.43 -3.64 -3.29 -4.61 -28 -8.00 -11
Other Investing Activities, net
- - - -7.00 -10 0.00 - - -8.00 -2.50 -2.00
Net Cash From Financing Activities
-1.63 0.74 -0.18 1.47 0.17 3.94 2.60 2.32 2.43 0.46 152
Net Cash From Continuing Financing Activities
-1.63 0.74 -0.18 1.47 0.17 3.94 2.60 2.32 2.43 0.46 152
Repayment of Debt
-1.56 -223 -0.24 -0.23 7.23 -0.24 -0.80 -2.84 -1.03 -0.79 -1.08
Issuance of Common Equity
0.49 3.53 0.06 1.70 0.44 4.18 0.28 5.15 3.46 1.25 1.38
Effect of Exchange Rate Changes
-1.08 0.55 0.46 -1.14 -1.60 0.88 1.46 -0.02 -0.00 -0.26 -0.16

Annual Balance Sheets for Artivion

This table presents Artivion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
181 316 590 571 606 789 793 763 792 789 885
Total Current Assets
110 147 179 179 187 235 248 247 281 290 358
Cash & Equivalents
38 57 40 41 34 61 55 39 59 53 65
Accounts Receivable
27 30 51 51 56 49 58 70 74 86 104
Inventories, net
15 26 47 45 53 73 77 74 82 80 92
Prepaid Expenses
5.19 2.82 4.73 6.85 12 14 15 18 16 19 43
Other Current Assets
25 31 36 33 33 37 43 46 50 52 55
Plant, Property, & Equipment, net
11 19 34 31 32 33 38 39 38 36 65
Total Noncurrent Assets
60 150 377 361 386 522 508 477 473 463 462
Goodwill
11 78 188 189 187 260 250 244 247 241 254
Intangible Assets
20 67 179 160 158 227 201 183 172 156 156
Noncurrent Deferred & Refundable Income Taxes
18 - 1.61 4.11 5.48 1.45 2.36 1.31 1.09 1.07 1.20
Other Noncurrent Operating Assets
5.58 5.47 7.49 7.92 36 33 54 49 53 64 50
Total Liabilities & Shareholders' Equity
181 316 590 571 606 789 793 763 792 789 885
Total Liabilities
26 107 313 296 320 461 492 478 511 513 437
Total Current Liabilities
20 30 43 35 45 60 45 50 58 67 102
Short-Term Debt
- 4.56 1.30 1.16 1.16 18 1.63 1.61 1.45 0.20 21
Accounts Payable
4.59 5.74 9.77 7.55 9.80 9.62 10 12 13 18 16
Accrued Expenses
7.29 9.86 15 11 11 11 11 14 12 14 20
Current Deferred & Payable Income Tax Liabilities
- 0.00 4.02 2.25 2.98 2.81 3.63 2.64 3.84 2.93 7.49
Current Employee Benefit Liabilities
6.34 8.82 10 11 12 10 13 14 19 18 22
Other Current Liabilities
1.39 1.12 2.43 2.33 7.90 9.13 4.76 5.13 6.37 5.67 10
Other Current Nonoperating Liabilities
- - - - - - - - 2.28 8.17 4.82
Total Noncurrent Liabilities
6.32 77 270 262 275 400 447 429 453 446 335
Long-Term Debt
- 67 218 216 215 290 307 306 306 314 215
Capital Lease Obligations
- 0.01 6.86 5.94 5.42 5.30 4.37 3.64 3.41 2.83 2.70
Noncurrent Deferred & Payable Income Tax Liabilities
- 0.01 30 27 26 35 29 24 22 20 24
Noncurrent Employee Benefit Liabilities
1.93 2.60 3.39 3.25 4.43 5.52 5.95 5.47 6.76 7.98 9.46
Other Noncurrent Operating Liabilities
2.66 5.07 7.89 6.87 24 64 101 89 115 101 83
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
155 209 277 275 286 329 301 284 282 276 448
Total Preferred & Common Equity
155 209 277 275 286 329 301 284 282 276 448
Preferred Stock
- - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
155 209 277 275 286 329 301 284 282 276 448
Common Stock
143 187 250 261 272 317 323 338 356 377 517
Retained Earnings
23 34 38 35 37 20 1.98 -17 -48 -61 -51
Treasury Stock
-11 -12 -13 -15 - -15 -15 -15 -15 -15 -15
Accumulated Other Comprehensive Income / (Loss)
-0.08 -0.43 1.86 -6.07 -8.59 6.74 -9.89 -22 -12 -25 -2.72

Quarterly Balance Sheets for Artivion

This table presents Artivion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
757 778 775 784 790 803 791 838 858 883 1,072
Total Current Assets
241 264 267 277 285 288 287 319 337 358 371
Cash & Equivalents
31 49 53 51 55 56 38 53 73 56 77
Accounts Receivable
67 69 68 77 79 78 96 101 97 106 111
Inventories, net
76 78 79 82 81 84 82 87 91 98 103
Prepaid Expenses
20 19 17 17 20 19 20 25 22 45 27
Other Current Assets
47 48 49 50 51 50 52 53 54 53 53
Plant, Property, & Equipment, net
39 38 37 38 37 38 38 40 41 68 74
Total Noncurrent Assets
478 476 470 469 467 477 466 479 479 458 627
Goodwill
246 246 243 245 244 249 245 254 254 252 350
Intangible Assets
181 177 172 168 164 165 156 158 157 155 224
Noncurrent Deferred & Refundable Income Taxes
2.37 3.95 3.71 0.67 3.31 1.46 0.68 0.69 0.60 1.14 1.22
Other Noncurrent Operating Assets
49 49 52 56 55 62 64 67 68 50 52
Total Liabilities & Shareholders' Equity
757 778 775 784 790 803 791 838 858 883 1,072
Total Liabilities
477 495 503 489 494 498 497 418 419 433 626
Total Current Liabilities
44 56 55 46 51 153 52 67 86 93 107
Short-Term Debt
1.62 1.56 1.55 0.27 0.27 100 0.14 0.07 19 21 25
Accounts Payable
9.47 10 11 10 12 11 12 19 16 18 21
Accrued Expenses
12 12 12 17 18 17 14 14 15 19 18
Current Deferred & Payable Income Tax Liabilities
6.91 11 9.39 2.09 1.73 3.52 1.61 2.85 2.07 7.13 5.58
Current Employee Benefit Liabilities
9.03 13 14 11 14 15 12 16 18 14 18
Other Current Liabilities
5.10 8.67 7.55 4.91 4.90 5.89 5.95 8.77 10 8.20 13
Other Current Nonoperating Liabilities
- - - - - - 6.76 5.71 5.59 4.48 6.53
Total Noncurrent Liabilities
433 439 448 443 444 346 445 352 333 340 519
Long-Term Debt
306 306 306 313 313 214 315 216 215 215 363
Capital Lease Obligations
3.58 3.45 3.27 3.27 3.20 3.19 3.02 3.06 2.88 3.05 2.80
Noncurrent Deferred & Payable Income Tax Liabilities
24 19 20 22 22 19 22 23 22 28 26
Noncurrent Employee Benefit Liabilities
6.13 6.54 6.46 7.45 7.46 7.93 8.07 8.73 9.19 9.74 11
Other Noncurrent Operating Liabilities
93 104 113 97 98 102 98 101 84 84 117
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
280 283 272 295 295 305 294 420 439 450 446
Total Preferred & Common Equity
280 283 272 295 295 305 294 420 439 450 446
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
280 283 272 295 295 305 294 420 439 450 446
Common Stock
343 347 352 364 368 374 389 498 510 527 536
Retained Earnings
-31 -34 -44 -40 -42 -45 -62 -60 -54 -50 -64
Treasury Stock
-15 -15 -15 -15 -15 -15 -15 -15 -15 -15 -15
Accumulated Other Comprehensive Income / (Loss)
-18 -16 -21 -14 -16 -9.53 -19 -2.83 -2.29 -12 -12

Annual Metrics And Ratios for Artivion

This table displays calculated financial ratios and metrics derived from Artivion's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.87% 23.63% 5.17% 38.55% 5.09% -8.32% 18.01% 5.00% 12.82% 9.76% 13.59%
EBITDA Growth
-25.08% 177.34% -39.61% 51.69% 25.10% -41.31% 29.67% -1.63% 0.69% 106.79% 23.61%
EBIT Growth
-41.31% 339.08% -61.51% 11.43% 72.20% -104.39% 385.86% 56.13% -14.78% 998.82% 49.36%
NOPAT Growth
-50.86% 249.54% -35.10% -21.37% 173.53% -90.42% 232.53% -23.60% -7.40% 577.01% -18.04%
Net Income Growth
-45.30% 169.11% -65.63% -176.67% 160.56% -1,069.88% 11.08% -29.38% -59.91% 56.47% 173.12%
EPS Growth
-44.00% 128.57% -65.63% -172.73% 162.50% -980.00% 13.64% -26.32% -56.25% 57.33% 165.63%
Operating Cash Flow Growth
40.95% 72.34% -45.22% -8.53% 60.18% -21.85% -120.90% -99.34% 465.32% 18.12% 79.35%
Free Cash Flow Firm Growth
627.53% -8,007.48% -134.41% 105.87% -93.17% -11,524.68% 125.14% -74.35% 269.70% -42.01% -484.37%
Invested Capital Growth
2.20% 99.61% 107.27% -1.52% 3.71% 22.77% -3.61% -0.44% -3.81% 2.35% 14.33%
Revenue Q/Q Growth
1.88% 2.96% 4.29% 6.04% -20.04% 37.71% 4.00% 0.00% 4.20% 0.95% 4.42%
EBITDA Q/Q Growth
41.76% 2.68% -16.69% 16.11% 10.58% 1.94% -55.71% 339.88% -10.26% -18.43% 47.34%
EBIT Q/Q Growth
230.84% -0.16% -35.49% 35.17% 20.27% -188.75% -94.29% 109.20% -55.82% -30.13% 100.21%
NOPAT Q/Q Growth
37.97% 71.62% -60.63% 46.92% 57.33% -41.29% -81.05% 185.32% -14.30% 790.00% 23.80%
Net Income Q/Q Growth
27.35% 2.48% -61.45% 44.00% 5.85% -19.97% -920.46% 53.71% -25.03% -1,469.80% 206.86%
EPS Q/Q Growth
55.56% -5.88% -59.26% 42.86% 25.00% -18.92% -1,050.00% 53.40% -25.00% -1,500.00% 184.00%
Operating Cash Flow Q/Q Growth
-22.75% 22.56% 9.44% 85.14% -37.41% 55.02% -220.29% -22.11% 142.28% -3.05% 30.93%
Free Cash Flow Firm Q/Q Growth
-79.94% 6.73% -4,405.99% 106.21% -93.57% -14.08% 211.08% -82.55% 435.05% 136.16% -138.41%
Invested Capital Q/Q Growth
3.98% 1.13% 95.71% -0.80% 3.57% 5.10% -2.48% 5.20% 1.19% -3.12% 3.18%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
62.18% 131.83% 67.81% 65.81% 66.26% 66.26% 66.09% 64.54% 64.74% 64.03% 64.40%
EBITDA Margin
7.36% 16.50% 9.48% 10.37% 12.35% 7.91% 8.69% 8.14% 7.26% 13.68% 14.89%
Operating Margin
3.67% 12.10% 4.20% 3.54% 6.17% 0.96% 2.72% 1.98% 1.62% 10.01% 7.65%
EBIT Margin
3.34% 11.85% 4.34% 3.49% 5.72% -0.27% 0.66% 0.99% 0.74% 7.45% 9.80%
Profit (Net Income) Margin
2.75% 5.98% 1.95% -1.08% 0.62% -6.59% -4.96% -6.12% -8.67% -3.44% 2.21%
Tax Burden Percent
68.25% 58.54% 104.02% 44.44% 104.62% 97.14% 100.05% 128.08% 142.18% 177.79% 66.09%
Interest Burden Percent
120.49% 86.11% 43.27% -69.69% 10.41% 2,478.21% -748.46% -484.45% -818.89% -25.94% 34.16%
Effective Tax Rate
31.75% 41.46% -4.02% 0.00% -4.62% 0.00% 0.00% 0.00% 0.00% 0.00% 33.91%
Return on Invested Capital (ROIC)
3.30% 7.62% 2.42% 1.42% 3.84% 0.32% 1.00% 0.78% 0.74% 5.02% 3.80%
ROIC Less NNEP Spread (ROIC-NNEP)
2.45% 21.30% -2.17% -3.69% -4.93% -8.07% -7.05% -8.09% -12.46% -10.41% -1.77%
Return on Net Nonoperating Assets (RNNOA)
-0.67% -1.71% -0.89% -2.45% -3.23% -5.75% -5.71% -7.34% -11.58% -9.81% -1.10%
Return on Equity (ROE)
2.64% 5.92% 1.52% -1.03% 0.61% -5.43% -4.71% -6.56% -10.84% -4.79% 2.70%
Cash Return on Invested Capital (CROIC)
1.13% -58.87% -67.41% 2.95% 0.20% -20.12% 4.67% 1.22% 4.62% 2.70% -9.58%
Operating Return on Assets (OROA)
2.73% 8.60% 1.82% 1.58% 2.68% -0.10% 0.25% 0.40% 0.34% 3.66% 5.17%
Return on Assets (ROA)
2.24% 4.33% 0.82% -0.49% 0.29% -2.39% -1.87% -2.47% -3.95% -1.69% 1.17%
Return on Common Equity (ROCE)
2.64% 5.92% 1.52% -1.03% 0.61% -5.43% -4.71% -6.56% -10.84% -4.79% 2.70%
Return on Equity Simple (ROE_SIMPLE)
2.58% 5.16% 1.34% -1.03% 0.60% -5.07% -4.93% -6.75% -10.89% -4.84% 0.00%
Net Operating Profit after Tax (NOPAT)
3.65 13 8.29 6.52 18 1.71 5.68 4.34 4.02 27 22
NOPAT Margin
2.50% 7.08% 4.37% 2.48% 6.45% 0.67% 1.90% 1.38% 1.14% 7.00% 5.05%
Net Nonoperating Expense Percent (NNEP)
0.85% -13.68% 4.59% 5.11% 8.77% 8.39% 8.05% 8.87% 13.19% 15.44% 5.57%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 0.73% 0.68% 4.59% 3.25%
Cost of Revenue to Revenue
37.82% -31.83% 32.19% 34.19% 33.74% 33.74% 33.91% 35.46% 35.26% 35.97% 35.60%
SG&A Expenses to Revenue
51.36% 50.75% 53.35% 53.48% 51.77% 55.74% 56.81% 50.17% 59.03% 46.70% 51.32%
R&D to Revenue
7.15% 7.45% 10.26% 8.79% 8.31% 9.56% 11.89% 12.39% 8.11% 7.32% 7.02%
Operating Expenses to Revenue
58.51% 58.21% 63.61% 62.27% 60.09% 65.29% 63.38% 62.57% 63.12% 54.03% 56.76%
Earnings before Interest and Taxes (EBIT)
4.87 21 8.23 9.17 16 -0.69 1.98 3.09 2.64 29 43
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
11 30 18 27 34 20 26 26 26 53 66
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.98 3.01 2.31 3.81 3.56 2.79 2.66 1.72 2.60 4.34 4.82
Price to Tangible Book Value (P/TBV)
2.47 9.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 57.40
Price to Revenue (P/Rev)
2.10 3.49 3.38 3.99 3.68 3.62 2.68 1.56 2.07 3.08 4.90
Price to Earnings (P/E)
76.59 5.17 172.98 0.00 590.68 0.00 0.00 0.00 0.00 0.00 221.21
Dividend Yield
1.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.31% 19.36% 0.58% 0.00% 0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.45%
Enterprise Value to Invested Capital (EV/IC)
2.40 2.88 1.79 2.70 2.55 2.01 1.89 1.37 1.84 2.67 3.73
Enterprise Value to Revenue (EV/Rev)
1.84 3.57 4.36 4.68 4.35 4.62 3.54 2.43 2.78 3.76 5.29
Enterprise Value to EBITDA (EV/EBITDA)
25.00 21.61 45.97 45.10 35.26 58.39 40.79 29.81 38.32 27.50 35.52
Enterprise Value to EBIT (EV/EBIT)
55.10 30.08 100.41 134.09 76.17 0.00 534.50 246.10 373.82 50.48 53.96
Enterprise Value to NOPAT (EV/NOPAT)
73.43 50.36 99.68 188.65 67.46 684.06 186.35 175.36 245.16 53.73 104.67
Enterprise Value to Operating Cash Flow (EV/OCF)
23.45 32.62 76.49 124.45 76.00 94.50 0.00 0.00 52.35 65.76 58.53
Enterprise Value to Free Cash Flow (EV/FCFF)
215.14 0.00 0.00 90.67 1,297.79 0.00 39.78 111.50 39.04 99.91 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.34 0.82 0.81 0.77 0.95 1.04 1.10 1.10 1.15 0.53
Long-Term Debt to Equity
0.00 0.32 0.81 0.81 0.77 0.90 1.04 1.09 1.10 1.15 0.49
Financial Leverage
-0.27 -0.08 0.41 0.66 0.66 0.71 0.81 0.91 0.93 0.94 0.62
Leverage Ratio
1.18 1.37 1.86 2.10 2.10 2.27 2.51 2.66 2.75 2.83 2.31
Compound Leverage Factor
1.42 1.18 0.81 -1.47 0.22 56.27 -18.82 -12.88 -22.50 -0.74 0.79
Debt to Total Capital
0.00% 25.51% 44.97% 44.75% 43.63% 48.81% 51.04% 52.30% 52.42% 53.45% 34.73%
Short-Term Debt to Total Capital
0.00% 1.63% 0.26% 0.23% 0.23% 2.74% 0.27% 0.27% 0.25% 0.03% 3.01%
Long-Term Debt to Total Capital
0.00% 23.89% 44.71% 44.52% 43.40% 46.06% 50.77% 52.03% 52.17% 53.42% 31.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 74.49% 55.03% 55.25% 56.37% 51.19% 48.96% 47.70% 47.58% 46.55% 65.27%
Debt to EBITDA
0.00 2.40 12.59 8.17 6.48 15.65 12.08 12.21 12.07 5.97 3.63
Net Debt to EBITDA
0.00 0.48 10.33 6.62 5.48 12.56 9.96 10.67 9.78 4.96 2.64
Long-Term Debt to EBITDA
0.00 2.25 12.52 8.13 6.45 14.77 12.01 12.15 12.02 5.96 3.31
Debt to NOPAT
0.00 5.60 27.31 34.18 12.40 183.41 55.17 71.82 77.22 11.66 10.69
Net Debt to NOPAT
0.00 1.12 22.39 27.70 10.48 147.15 45.49 62.75 62.56 9.69 7.78
Long-Term Debt to NOPAT
0.00 5.25 27.15 34.01 12.34 173.10 54.89 71.45 76.86 11.65 9.77
Altman Z-Score
8.77 4.91 1.96 3.03 2.81 1.81 1.67 1.32 1.57 2.25 3.90
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.59 4.89 4.18 5.19 4.15 3.88 5.51 4.98 4.85 4.34 3.53
Quick Ratio
3.28 2.88 2.13 2.69 1.98 1.82 2.52 2.19 2.30 2.09 1.66
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1.25 -99 -231 14 0.93 -106 27 6.83 25 15 -56
Operating Cash Flow to CapEx
327.85% 318.15% 162.89% 170.77% 196.07% 168.79% 0.00% -48.09% 0.00% 198.75% 117.15%
Free Cash Flow to Firm to Interest Expense
0.00 -32.41 -47.36 0.86 0.06 -6.34 1.58 0.37 1.00 0.39 -1.92
Operating Cash Flow to Interest Expense
0.00 6.48 2.21 0.63 1.06 0.74 -0.15 -0.28 0.74 0.59 1.36
Operating Cash Flow Less CapEx to Interest Expense
0.00 4.44 0.85 0.26 0.52 0.30 0.20 -0.87 0.92 0.29 0.20
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.82 0.73 0.42 0.45 0.47 0.36 0.38 0.40 0.46 0.49 0.53
Accounts Receivable Turnover
5.89 6.36 4.65 5.11 5.15 4.84 5.59 4.91 4.93 4.86 4.66
Inventory Turnover
4.03 0.00 1.67 1.95 1.89 1.36 1.35 1.47 1.60 1.73 1.82
Fixed Asset Turnover
12.42 12.03 7.28 8.14 8.74 7.76 8.47 8.24 9.19 10.39 8.71
Accounts Payable Turnover
12.14 0.00 7.87 10.38 10.75 8.80 10.12 9.93 9.86 8.93 9.24
Days Sales Outstanding (DSO)
61.96 57.44 78.44 71.43 70.89 75.39 65.26 74.26 74.09 75.17 78.39
Days Inventory Outstanding (DIO)
90.56 0.00 218.12 187.18 192.96 269.36 270.19 248.41 228.74 211.21 200.03
Days Payable Outstanding (DPO)
30.05 0.00 46.36 35.16 33.96 41.48 36.06 36.74 37.02 40.86 39.51
Cash Conversion Cycle (CCC)
122.47 57.44 250.20 223.45 229.89 303.28 299.40 285.93 265.81 245.52 238.91
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
112 223 463 456 473 580 559 557 536 548 627
Invested Capital Turnover
1.32 1.08 0.55 0.57 0.60 0.48 0.52 0.56 0.65 0.72 0.75
Increase / (Decrease) in Invested Capital
2.41 111 239 -7.04 17 108 -21 -2.49 -21 13 79
Enterprise Value (EV)
268 643 826 1,230 1,203 1,169 1,059 761 985 1,462 2,334
Market Capitalization
307 629 641 1,049 1,016 917 800 489 734 1,198 2,161
Book Value per Share
$5.46 $6.36 $8.28 $7.44 $7.62 $8.46 $7.65 $7.05 $6.86 $6.59 $9.46
Tangible Book Value per Share
$4.36 $1.95 ($2.71) ($2.00) ($1.57) ($4.08) ($3.83) ($3.52) ($3.36) ($2.89) $0.79
Total Capital
155 281 503 498 507 642 614 596 592 593 687
Total Debt
0.00 72 226 223 221 313 313 312 310 317 239
Total Long-Term Debt
0.00 67 225 222 220 296 312 310 309 317 218
Net Debt
-38 14 186 181 187 251 258 272 251 264 174
Capital Expenditures (CapEx)
3.49 6.20 6.63 5.79 8.07 7.33 -5.91 11 -4.50 11 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
52 64 97 104 109 130 149 160 165 170 212
Debt-free Net Working Capital (DFNWC)
90 122 138 146 143 192 204 199 224 223 277
Net Working Capital (NWC)
90 117 136 145 142 174 203 198 223 223 257
Net Nonoperating Expense (NNE)
-0.35 1.99 4.59 9.36 16 18 21 24 35 41 13
Net Nonoperating Obligations (NNO)
-43 14 186 181 187 251 258 272 254 272 178
Total Depreciation and Amortization (D&A)
5.86 8.38 9.75 18 18 21 24 22 23 24 22
Debt-free, Cash-free Net Working Capital to Revenue
35.39% 35.68% 51.07% 39.40% 39.48% 51.25% 49.98% 50.96% 46.70% 43.75% 48.11%
Debt-free Net Working Capital to Revenue
61.73% 67.46% 72.55% 55.47% 51.90% 75.72% 68.39% 63.50% 63.35% 57.51% 62.81%
Net Working Capital to Revenue
61.73% 64.94% 71.87% 55.03% 51.48% 68.76% 67.84% 62.99% 62.94% 57.46% 58.13%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.14 $0.33 $0.11 ($0.08) $0.05 ($0.44) ($0.38) ($0.48) ($0.75) ($0.32) $0.22
Adjusted Weighted Average Basic Shares Outstanding
27.74M 31.86M 33.01M 36.41M 37.12M 37.86M 38.98M 40.03M 40.74M 41.68M 45.34M
Adjusted Diluted Earnings per Share
$0.14 $0.32 $0.11 ($0.08) $0.05 ($0.44) ($0.38) ($0.48) ($0.75) ($0.32) $0.21
Adjusted Weighted Average Diluted Shares Outstanding
28.54M 32.82M 34.16M 36.41M 37.86M 37.86M 38.98M 40.03M 40.74M 41.68M 47.16M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
32.25M 32.98M 36.49M 37.02M 39.08M 38.96M 40.12M 40.56M 41.23M 42.05M 47.88M
Normalized Net Operating Profit after Tax (NOPAT)
3.65 13 5.58 6.52 12 1.71 -5.46 4.34 -5.96 27 18
Normalized NOPAT Margin
2.50% 7.08% 2.94% 2.48% 4.32% 0.67% -1.83% 1.38% -1.68% 7.00% 4.01%
Pre Tax Income Margin
4.02% 10.21% 1.88% -2.43% 0.60% -6.78% -4.96% -4.78% -6.10% -1.93% 3.35%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 7.03 1.69 0.58 1.06 -0.04 0.12 0.17 0.10 0.76 1.48
NOPAT to Interest Expense
0.00 4.20 1.70 0.41 1.20 0.10 0.34 0.24 0.16 0.72 0.76
EBIT Less CapEx to Interest Expense
0.00 4.99 0.33 0.21 0.52 -0.48 0.47 -0.42 0.28 0.47 0.32
NOPAT Less CapEx to Interest Expense
0.00 2.16 0.34 0.05 0.66 -0.34 0.69 -0.35 0.34 0.42 -0.40
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
85.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
85.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Artivion

This table displays calculated financial ratios and metrics derived from Artivion's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 47,883,897.00 48,543,350.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 47,883,897.00 48,543,350.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.03 -0.28
Growth Metrics
- - - - - - - - - - -
Revenue Growth
17.98% 17.06% 9.82% 9.02% 3.88% 1.59% 15.26% 18.39% 19.20% 17.54% 11.32%
EBITDA Growth
-20.99% 951.16% 24.06% 394.74% -108.48% -64.21% 42.11% 44.78% 2,248.78% 10.97% -88.07%
EBIT Growth
-38.80% 924.78% 60.86% 314.68% -237.66% -78.14% 93.41% 90.98% 299.34% 5.30% -145.05%
NOPAT Growth
-18.77% 651.97% -15.22% 452.65% -15.86% -89.94% -28.90% 276.17% 112.15% 1,511.01% -280.79%
Net Income Growth
-283.26% 155.67% 37.29% 76.66% -314.67% -106.70% 163.41% 384.18% 114.72% 380.59% -1,104.46%
EPS Growth
-300.00% 154.55% 37.50% 79.17% -300.00% -105.56% 160.00% 360.00% 115.00% 400.00% -1,033.33%
Operating Cash Flow Growth
5,094.47% 10.74% -11.20% 58.39% -6.45% -208.63% 144.68% 94.34% 92.92% 106.81% -108.43%
Free Cash Flow Firm Growth
349.07% 457.47% -153.04% -3,865.64% -145.69% -226.65% -315.75% 10.18% -596.54% -76.36% -488.72%
Invested Capital Growth
-3.81% -0.04% 2.19% 6.90% 2.35% 3.69% 6.11% 7.35% 14.33% 9.98% 29.66%
Revenue Q/Q Growth
6.62% 4.02% 0.60% -2.29% 1.60% 1.72% 14.14% 0.37% 2.30% 0.30% 8.10%
EBITDA Q/Q Growth
325.15% 169.27% -61.71% 12.86% -107.29% 1,236.32% 52.03% 14.98% 8.18% -41.31% -83.66%
EBIT Q/Q Growth
266.56% 354.84% -76.89% 22.61% -206.81% 172.21% 104.52% 21.07% 11.48% -61.85% -187.49%
NOPAT Q/Q Growth
354.98% 571.86% -69.47% -32.58% -39.16% -19.63% 115.68% 256.70% -65.69% 510.30% -124.20%
Net Income Q/Q Growth
59.44% 289.51% -128.16% -7.87% -620.41% 96.94% 366.34% 383.42% -62.69% -41.59% -1,053.42%
EPS Q/Q Growth
58.33% 280.00% -127.78% 0.00% -700.00% 97.50% 400.00% 333.33% -53.85% -50.00% -1,033.33%
Operating Cash Flow Q/Q Growth
49.86% -150.68% 211.69% 86.72% -11.49% -267.21% 188.54% 48.30% -12.14% -94.10% -209.71%
Free Cash Flow Firm Q/Q Growth
2,877.84% -35.43% -148.88% -352.31% 68.00% -78.99% -60.47% 2.28% -148.16% 54.68% -435.66%
Invested Capital Q/Q Growth
1.19% 4.65% -0.64% 1.60% -3.12% 6.02% 1.67% 2.80% 3.18% 1.98% 19.86%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
65.22% 64.61% 64.60% 63.70% 63.20% 64.23% 64.72% 65.61% 63.06% 64.85% 64.03%
EBITDA Margin
11.82% 30.60% 11.65% 13.45% -0.97% 10.78% 14.36% 16.45% 17.40% 10.18% 1.54%
Operating Margin
3.39% 25.98% 6.64% 4.58% 2.74% 2.17% 7.42% 11.06% 9.21% 4.97% -6.65%
EBIT Margin
5.61% 24.53% 5.64% 7.07% -7.43% 5.28% 9.46% 11.41% 12.43% 4.73% -3.83%
Profit (Net Income) Margin
-4.24% 7.73% -2.16% -2.39% -16.94% -0.51% 1.19% 5.73% 2.09% 1.22% -10.74%
Tax Burden Percent
672.59% 58.94% 87.39% 180.73% 99.28% 22.00% 38.63% 92.15% 37.11% 417.99% 115.48%
Interest Burden Percent
-11.25% 53.47% -43.94% -18.69% 229.50% -43.93% 32.59% 54.55% 45.33% 6.16% 243.07%
Effective Tax Rate
0.00% 41.06% 0.00% 0.00% 0.00% 0.00% 61.37% 7.85% 62.89% -317.99% 0.00%
Return on Invested Capital (ROIC)
1.54% 10.06% 3.18% 2.25% 1.38% 1.04% 2.02% 7.34% 2.57% 15.63% -3.24%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.82% 7.35% 0.63% 0.19% -5.61% 0.31% 1.15% 4.99% 1.88% 6.05% -6.35%
Return on Net Nonoperating Assets (RNNOA)
-0.76% 6.99% 0.57% 0.17% -5.28% 0.29% 0.69% 2.88% 1.17% 3.86% -3.61%
Return on Equity (ROE)
0.78% 17.04% 3.75% 2.42% -3.90% 1.33% 2.72% 10.23% 3.74% 19.50% -6.84%
Cash Return on Invested Capital (CROIC)
4.62% -525.87% -151.13% -7.39% 2.70% -1.69% -3.78% -4.02% -9.58% -5.39% -30.14%
Operating Return on Assets (OROA)
2.55% 11.72% 2.71% 3.45% -3.65% 2.61% 4.71% 5.81% 6.56% 2.59% -1.89%
Return on Assets (ROA)
-1.93% 3.69% -1.04% -1.17% -8.32% -0.25% 0.59% 2.92% 1.10% 0.67% -5.30%
Return on Common Equity (ROCE)
0.78% 17.04% 3.75% 2.42% -3.90% 1.33% 2.72% 10.23% 3.74% 19.50% -6.84%
Return on Equity Simple (ROE_SIMPLE)
0.00% -3.26% -2.83% -0.28% 0.00% -7.27% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
2.22 15 4.55 3.07 1.87 1.50 3.24 12 3.96 24 -5.85
NOPAT Margin
2.37% 15.31% 4.65% 3.21% 1.92% 1.52% 2.87% 10.19% 3.42% 20.79% -4.66%
Net Nonoperating Expense Percent (NNEP)
2.36% 2.70% 2.55% 2.07% 6.98% 0.73% 0.88% 2.35% 0.68% 9.58% 3.12%
Return On Investment Capital (ROIC_SIMPLE)
0.38% 2.44% - - 0.31% 0.25% 0.51% 1.71% 0.58% 3.50% -0.70%
Cost of Revenue to Revenue
34.78% 35.39% 35.40% 36.30% 36.80% 35.77% 35.28% 34.39% 36.94% 35.15% 35.97%
SG&A Expenses to Revenue
53.68% 31.50% 50.32% 52.22% 52.85% 55.27% 51.04% 50.52% 49.00% 52.28% 63.48%
R&D to Revenue
8.16% 7.13% 7.65% 6.90% 7.61% 6.80% 6.25% 7.12% 7.86% 7.60% 7.20%
Operating Expenses to Revenue
61.84% 38.63% 57.97% 59.12% 60.46% 62.07% 57.30% 54.56% 53.85% 59.88% 70.68%
Earnings before Interest and Taxes (EBIT)
5.26 24 5.52 6.77 -7.23 5.22 11 13 14 5.50 -4.81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
11 30 11 13 -0.94 11 16 19 20 12 1.94
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.60 2.94 3.63 3.66 4.34 3.51 3.16 4.55 4.82 3.89 2.45
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 173.38 71.71 57.40 39.93 0.00
Price to Revenue (P/Rev)
2.07 2.36 2.84 2.90 3.08 2.65 3.28 4.73 4.90 3.82 2.31
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 221.21 150.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.45% 0.67% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.84 2.02 2.39 2.43 2.67 2.26 2.53 3.56 3.73 3.03 1.83
Enterprise Value to Revenue (EV/Rev)
2.78 3.08 3.53 3.58 3.76 3.37 3.69 5.11 5.29 4.22 2.98
Enterprise Value to EBITDA (EV/EBITDA)
38.32 21.52 24.27 21.11 27.50 38.60 38.45 48.44 35.52 28.97 26.70
Enterprise Value to EBIT (EV/EBIT)
373.82 38.52 42.26 33.20 50.48 127.70 96.67 100.00 53.96 44.50 50.09
Enterprise Value to NOPAT (EV/NOPAT)
245.16 0.00 0.00 0.00 53.73 119.47 121.31 119.95 104.67 77.20 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
52.35 58.20 71.20 60.00 65.76 121.90 75.98 70.94 58.53 33.41 33.68
Enterprise Value to Free Cash Flow (EV/FCFF)
39.04 0.00 0.00 0.00 99.91 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.10 1.07 1.07 1.04 1.15 1.08 0.52 0.54 0.53 0.53 0.88
Long-Term Debt to Equity
1.10 1.07 1.07 0.71 1.15 1.08 0.52 0.50 0.49 0.48 0.82
Financial Leverage
0.93 0.95 0.91 0.90 0.94 0.94 0.61 0.58 0.62 0.64 0.57
Leverage Ratio
2.75 2.68 2.71 2.74 2.83 2.67 2.28 2.23 2.31 2.25 2.21
Compound Leverage Factor
-0.31 1.43 -1.19 -0.51 6.50 -1.17 0.74 1.22 1.05 0.14 5.37
Debt to Total Capital
52.42% 51.76% 51.77% 51.00% 53.45% 51.92% 34.24% 35.02% 34.73% 34.75% 46.75%
Short-Term Debt to Total Capital
0.25% 0.04% 0.04% 16.03% 0.03% 0.02% 0.01% 2.77% 3.01% 3.11% 2.99%
Long-Term Debt to Total Capital
52.17% 51.72% 51.73% 34.97% 53.42% 51.90% 34.23% 32.25% 31.72% 31.64% 43.76%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
47.58% 48.24% 48.23% 49.00% 46.55% 48.08% 65.76% 64.98% 65.27% 65.25% 53.25%
Debt to EBITDA
12.07 6.01 5.77 4.87 5.97 9.34 5.63 5.30 3.63 3.59 7.44
Net Debt to EBITDA
9.78 5.04 4.77 4.00 4.96 8.23 4.25 3.66 2.64 2.75 5.97
Long-Term Debt to EBITDA
12.02 6.00 5.76 3.34 5.96 9.33 5.63 4.88 3.31 3.26 6.96
Debt to NOPAT
77.22 -0.11 -0.39 -80.42 11.66 28.90 17.76 13.13 10.69 9.56 -13.37
Net Debt to NOPAT
62.56 -0.09 -0.32 -66.18 9.69 25.47 13.42 9.05 7.78 7.34 -10.73
Long-Term Debt to NOPAT
76.86 -0.11 -0.39 -55.14 11.65 28.89 17.76 12.09 9.77 8.70 -12.52
Altman Z-Score
1.58 1.92 2.08 1.97 2.10 2.01 2.69 3.67 3.79 3.25 1.68
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.85 6.04 5.63 1.88 4.34 5.53 4.78 3.93 3.53 3.86 3.47
Quick Ratio
2.30 2.79 2.65 0.88 2.09 2.57 2.32 1.99 1.66 1.74 1.76
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
23 15 -7.40 -33 -11 -19 -31 -30 -75 -34 -181
Operating Cash Flow to CapEx
406.07% -152.12% 244.13% 314.78% 711.51% -466.00% 456.68% 483.01% 71.11% 14.42% -11.78%
Free Cash Flow to Firm to Interest Expense
3.75 1.32 -0.89 -3.98 -1.10 -2.50 -4.23 -4.91 -9.10 -6.30 -24.97
Operating Cash Flow to Interest Expense
1.74 -0.48 0.74 1.36 1.04 -2.21 2.06 3.64 2.39 0.22 -0.17
Operating Cash Flow Less CapEx to Interest Expense
1.31 -0.79 0.44 0.93 0.89 -2.69 1.61 2.88 -0.97 -1.28 -1.66
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.46 0.48 0.48 0.49 0.49 0.50 0.50 0.51 0.53 0.55 0.49
Accounts Receivable Turnover
4.93 5.14 5.09 5.26 4.86 4.53 4.50 4.82 4.66 4.56 4.45
Inventory Turnover
1.60 1.64 1.67 1.68 1.73 1.72 1.74 1.72 1.82 1.81 1.77
Fixed Asset Turnover
9.19 9.63 9.94 10.17 10.39 10.32 10.45 10.70 8.71 8.69 8.29
Accounts Payable Turnover
9.86 13.08 12.02 12.43 8.93 12.75 9.36 10.86 9.24 10.83 8.34
Days Sales Outstanding (DSO)
74.09 71.02 71.75 69.34 75.17 80.62 81.20 75.71 78.39 80.12 82.07
Days Inventory Outstanding (DIO)
228.74 222.12 217.98 217.78 211.21 212.30 209.64 212.43 200.03 201.95 206.53
Days Payable Outstanding (DPO)
37.02 27.91 30.36 29.36 40.86 28.64 38.99 33.62 39.51 33.71 43.78
Cash Conversion Cycle (CCC)
265.81 265.23 259.37 257.76 245.52 264.29 251.85 254.53 238.91 248.37 244.81
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
536 560 557 566 548 581 591 607 627 639 766
Invested Capital Turnover
0.65 0.66 0.68 0.70 0.72 0.68 0.71 0.72 0.75 0.75 0.70
Increase / (Decrease) in Invested Capital
-21 -0.22 12 37 13 21 34 42 79 58 175
Enterprise Value (EV)
985 1,134 1,332 1,376 1,462 1,314 1,493 2,161 2,334 1,938 1,405
Market Capitalization
734 869 1,070 1,115 1,198 1,034 1,328 1,998 2,161 1,754 1,091
Book Value per Share
$6.86 $7.14 $7.07 $7.27 $6.59 $7.00 $9.83 $9.30 $9.46 $9.41 $9.18
Tangible Book Value per Share
($3.36) ($2.86) ($2.72) ($2.59) ($2.89) ($2.54) $0.18 $0.59 $0.79 $0.92 ($2.64)
Total Capital
592 612 612 622 593 612 639 675 687 690 837
Total Debt
310 317 317 317 317 318 219 236 239 240 391
Total Long-Term Debt
309 316 316 217 317 318 219 218 218 218 366
Net Debt
251 265 262 261 264 280 165 163 174 184 314
Capital Expenditures (CapEx)
2.67 3.61 2.51 3.64 1.43 3.64 3.29 4.61 28 8.00 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
165 180 180 179 170 198 199 197 212 231 212
Debt-free Net Working Capital (DFNWC)
224 231 235 235 223 235 252 270 277 286 289
Net Working Capital (NWC)
223 231 234 135 223 235 252 252 257 265 264
Net Nonoperating Expense (NNE)
6.20 7.39 6.68 5.36 18 2.01 1.89 5.05 1.54 23 7.66
Net Nonoperating Obligations (NNO)
254 265 262 261 272 287 171 169 178 189 320
Total Depreciation and Amortization (D&A)
5.82 5.91 5.89 6.11 6.30 5.45 5.54 5.72 5.76 6.34 6.75
Debt-free, Cash-free Net Working Capital to Revenue
46.70% 48.91% 47.65% 46.41% 43.75% 50.71% 49.07% 46.60% 48.11% 50.26% 44.99%
Debt-free Net Working Capital to Revenue
63.35% 62.80% 62.25% 61.01% 57.51% 60.37% 62.27% 63.98% 62.81% 62.42% 61.39%
Net Working Capital to Revenue
62.94% 62.72% 62.17% 35.11% 57.46% 60.34% 62.25% 59.54% 58.13% 57.73% 56.09%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.10) $0.18 ($0.05) ($0.05) ($0.40) ($0.01) $0.03 $0.14 $0.06 $0.03 ($0.28)
Adjusted Weighted Average Basic Shares Outstanding
40.74M 41.29M 41.68M 41.84M 41.68M 42.23M 44.30M 47.23M 45.34M 48.07M 48.54M
Adjusted Diluted Earnings per Share
($0.10) $0.18 ($0.05) ($0.05) ($0.40) ($0.01) $0.03 $0.13 $0.06 $0.03 ($0.28)
Adjusted Weighted Average Diluted Shares Outstanding
40.74M 47.89M 41.68M 41.84M 41.68M 42.23M 45.38M 48.78M 47.16M 49.73M 48.54M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
41.23M 41.73M 41.89M 41.92M 42.05M 42.70M 47.18M 47.37M 47.88M 48.54M 48.76M
Normalized Net Operating Profit after Tax (NOPAT)
2.22 15 4.55 3.07 1.87 1.50 5.87 8.33 7.48 4.05 -5.85
Normalized NOPAT Margin
2.37% 15.31% 4.65% 3.21% 1.92% 1.52% 5.19% 7.34% 6.45% 3.48% -4.66%
Pre Tax Income Margin
-0.63% 13.12% -2.48% -1.32% -17.06% -2.32% 3.08% 6.22% 5.64% 0.29% -9.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.84 2.08 0.67 0.81 -0.74 0.68 1.47 2.11 1.76 1.03 -0.66
NOPAT to Interest Expense
0.36 1.30 0.55 0.37 0.19 0.20 0.45 1.89 0.48 4.51 -0.81
EBIT Less CapEx to Interest Expense
0.41 1.77 0.36 0.37 -0.89 0.21 1.02 1.36 -1.60 -0.47 -2.15
NOPAT Less CapEx to Interest Expense
-0.07 0.98 0.25 -0.07 0.05 -0.28 -0.01 1.13 -2.87 3.02 -2.29
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Artivion’s recent financial statements show a company that has grown revenue steadily, but profitability remains uneven and debt is still a major consideration. Over the last four years, revenue has generally trended higher, while margins have improved at times but remain vulnerable to heavy interest expense, integration costs, and working-capital swings.

  • Revenue has continued to rise year over year, with Q1 2026 revenue of $116.3 million versus $98.0 million in Q2 2024 and $83.2 million in Q1 2023, showing a clear long-term growth trend.
  • Gross profit has also expanded over time, indicating the company has been able to grow sales faster than direct costs in many periods.
  • Operating income improved meaningfully in several recent quarters, including $10.7 million in Q4 2025 and $12.5 million in Q3 2025, suggesting stronger operating leverage when expenses are controlled.
  • Operating cash flow turned positive and solid in some recent periods, including $19.6 million in Q4 2025 and $22.3 million in Q3 2025, which is a constructive sign for the underlying business.
  • Cash and equivalents increased from $37.7 million at Q1 2025 to $55.8 million at Q1 2026, giving the company more liquidity than a year ago.
  • Total common equity has climbed over the past year, from $294.3 million at Q1 2025 to $450.5 million at Q1 2026, reflecting a stronger balance sheet on paper.
  • The company continues to invest in the business, with quarterly capital expenditures generally in the low- to mid-single-digit millions, and Q1 2026 PP&E purchases of $8.0 million were higher than recent quarters.
  • Share count has moved around but not dramatically, with diluted weighted average shares at 49.7 million in Q1 2026 versus 47.2 million in Q4 2025 and 42.2 million in Q1 2025, so dilution is worth watching but not yet extreme.
  • Q1 2026 was only barely profitable, with net income of $1.4 million and diluted EPS of $0.03, showing how thin earnings remain relative to revenue.
  • Interest expense remains a major drag. In Q1 2026, interest expense was $5.4 million versus operating income of only $5.8 million, leaving little room for error.
  • Debt is still substantial. At Q1 2026, Artivion carried about $21.5 million of short-term debt and $215.4 million of long-term debt.
  • Working capital can be volatile, and Q1 2026 operating cash flow was only $1.2 million after a negative $17.4 million change in operating assets and liabilities.

Bottom line: Artivion looks like a growing medical device company with improving revenue and periodic profit strength, but the investment case is still constrained by leverage, interest expense, and inconsistent free cash generation. If management can keep revenue growing while sustaining better operating margins, the financial profile could improve materially.

08/26/26 12:41 PM ETAI Generated. May Contain Errors.

Artivion Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Artivion's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Artivion's net income appears to be on an upward trend, with a most recent value of $9.77 million in 2025, rising from $4.01 million in 2015. The previous period was -$13.36 million in 2024. View Artivion's forecast to see where analysts expect Artivion to go next.

Artivion's total operating income in 2025 was $33.75 million, based on the following breakdown:
  • Total Gross Profit: $284.23 million
  • Total Operating Expenses: $250.48 million

Over the last 10 years, Artivion's total revenue changed from $145.90 million in 2015 to $441.33 million in 2025, a change of 202.5%.

Artivion's total liabilities were at $436.56 million at the end of 2025, a 14.9% decrease from 2024, and a 1,583.8% increase since 2015.

In the past 10 years, Artivion's cash and equivalents has ranged from $33.77 million in 2019 to $64.91 million in 2025, and is currently $64.91 million as of their latest financial filing in 2025.

Over the last 10 years, Artivion's book value per share changed from 5.46 in 2015 to 9.46 in 2025, a change of 73.4%.



Financial statements for NYSE:AORT last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners